StemSight
PrivateLast Round
Seed
Feb 11, 2025
Total Funding Raised
$1.89M
Momentum Score
25 /100
Company Overview
StemSight is a biotechnology company developing off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs) to treat corneal blindness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemSight Comps
Public and private peers based on sector, stage, and business model.
StemSight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 11, 2025 | ||||
| Pre Seed | Aug 31, 2021 |
Key People
Founding team and executive leadership
StemSight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Seed |
| Biothom Oy | Seed |
| European Regional Development Fund (ERDF) | Grant |
| Voima Ventures | Pre Seed, Seed |
| Avohoidon Tutkimussäätiö | Pre Seed |
| Stephen Industries Inc Oy | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 891% MoM.
- Jan 6, 2026
Monthly visitors grew 258% MoM, reaching 974.
StemSight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about StemSight's valuation, stock price, and market status.
